| DB ID | MyCo_4021 |
| Title | Gamma-glutamyl transpeptidase-platelet ratio, systemic immune inflammation index, and system inflammation response index in invasive Aspergillosis |
| Year | 2021 |
| PMID | 34817517 |
| Fungal Diseases involved | Invasive aspergillosis |
| Disease | Aspergillosis (Aspergillus Infection) |
| Associated Medical Condition | None |
| Genus | Aspergillus |
| Species | spp. |
| Organism | Aspergillus spp. |
| Ethical Statement | This study was approved by the University Medical Sciences Research Ethics Committee (Resolution number: TSA-11-3244). |
| Site of Infection | Unspecified |
| Opportunistic invasive | Invasive |
| Sample type | Body fluid |
| Sample source | Blood |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | Gamma-glutamyl transpeptidase-platelet ratio |
| Biomarker Full Name | Gamma-glutamyl transpeptidase-platelet ratio |
| Biomarker Type | Diagnostic |
| Biomolecule | NA |
| Geographical Location | Turkey |
| Cohort | A total of 23 patients with invasive aspergillosis and 23 sex- and age-matched healthy participants were included in this study. |
| Cohort No. | 23 Patients and 23 control |
| Age Group | None |
| P Value | p<0.001 |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Sub Technique | Chemiluminescence |
| Technique | Immunoassay |
| Analysis Method | Immunological assay |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | Immunological assay |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
